Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circulating Tumoral DNA in Choroidal Melanoma
NCT02875652Completed
- Sponsor
- Institut Curie
- Start
- Mar 2013
- Primary completion
- Apr 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Institut Curie. Primary endpoint: Assessment of the change of the circulating tumor DNA from baseline at 3 years. Started Mar 2013; status: completed.
Beyond the preview
Go deeper on NCT02875652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02875652.